SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

GeneDx Holdings Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD
68.53-2.99 (-4.18%)
 
Market Cap2.04B-43.3%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out29.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume659,215
Open70.31
Previous Close71.52
Day's Range68.39 - 71.43
52-Week Range32.21 - 170.87
Betan/a
AnalystsBuy
Price Target81.00(+18.20%)
Earnings Daten/a
Insider Score
––Not scored
WGS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About WGS

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Address
North Tower, Stamford, CT, 06902, United States
Market Cap
2.04 billion
Employees
1,300
Industrial Classification
Diagnostics & Research

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.55M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-4.18%
5 Days
-5.21%
1 Month
-20.19%
6 Months
+4.48%
1 Year
-43.25%

$WGS stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in WGS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by WGS's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

WGS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

WGS Revenue by Segment

$114.44MTotal
SegmentRevenue% of All
Diagnostic test revenue:$111.89M97.77%
Other$2.55M2.23%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New WGS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to WGS from public contracts

Source: USAspending.gov

WGS Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for WGS is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from WGS’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
18
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.